AAAAAA

   
Results: 1-9 |
Results: 9
Severe meningococcal shock with purpura fulminans: untoward result of genetic polymorphisms?
Authors: Mercier, JC Bingen, E Schlegel, N Elion, J Casanova, JL Mira, JP Beaufils, F
Citation: Jc. Mercier et al., Severe meningococcal shock with purpura fulminans: untoward result of genetic polymorphisms?, ARCH PED, 8(8), 2001, pp. 843-852
Importance of host reponse during severe bacterials infections
Authors: Charpentier, J Mira, JP
Citation: J. Charpentier et Jp. Mira, Importance of host reponse during severe bacterials infections, ARCH PED, 8, 2001, pp. 689S-696S
Question and answer session after scientific review
Authors: Ulevitch, R Calandra, T Mira, JP Grinnell, B Fisher, C
Citation: R. Ulevitch et al., Question and answer session after scientific review, CRIT CARE M, 29(7), 2001, pp. S15-S15
Clinical expert round table discussion (session 1) at the Margaux Conference on Critical Illness: Innate immunity: Host recognition of and sensitivity to bacterial components
Authors: Redl, HR Aderem, A Beutler, BA Calandra, T Mira, JP Ulevitch, R
Citation: Hr. Redl et al., Clinical expert round table discussion (session 1) at the Margaux Conference on Critical Illness: Innate immunity: Host recognition of and sensitivity to bacterial components, CRIT CARE M, 29(7), 2001, pp. S19-S20
Toll-like receptor 2-mediated NF-kappa B activation requires a RacI-dependent pathway
Authors: Arbibe, L Mira, JP Teusch, N Kline, L Guha, M Mackman, N Godowski, PJ Ulevitch, RJ Knaus, UG
Citation: L. Arbibe et al., Toll-like receptor 2-mediated NF-kappa B activation requires a RacI-dependent pathway, NAT IMMUNOL, 1(6), 2000, pp. 533-540
Endogenous, hyperactive Rac3 controls proliferation of breast cancer cellsby a p21-activated kinase-dependent pathway
Authors: Mira, JP Benard, V Groffen, J Sanders, LC Knaus, UG
Citation: Jp. Mira et al., Endogenous, hyperactive Rac3 controls proliferation of breast cancer cellsby a p21-activated kinase-dependent pathway, P NAS US, 97(1), 2000, pp. 185-189
A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection
Authors: Lorenz, E Mira, JP Cornish, KL Arbour, NC Schwartz, DA
Citation: E. Lorenz et al., A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection, INFEC IMMUN, 68(11), 2000, pp. 6398-6401
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality - A multicenter study
Authors: Mira, JP Cariou, A Grall, F Delclaux, C Losser, MR Heshmati, F Cheval, C Monchi, M Teboul, JL Riche, F Leleu, G Arbibe, L Mignon, A Delpech, M Dhainaut, JF
Citation: Jp. Mira et al., Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality - A multicenter study, J AM MED A, 282(6), 1999, pp. 561-568
Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial
Authors: Dhainaut, JFA Tenaillon, A Hemmer, M Damas, P Le Tulzo, Y Radermacher, P Schaller, MD Sollet, JP Wolff, M Holzapfel, L Zeni, F Vedrinne, JM de Vathaire, F Gourlay, ML Guinot, P Mira, JP Holzapfel, L Demingeon, G Piralla, B Zeni, F Bertrand, JC Motin, J Vedrinne, JM Dreyfuss, D Coste, F Mier, L Faller, JP Ruyer, O Feissel, M Engquist, A Strom, J Bonde, J Desmonts, JM Montravers, P Lagoueyte, JF Tenaillon, A Lawkoune, JM Boiteau, R Cardinaud, JP Benissan, G Chastre, J Gibert, C Daoudal, P Delacourt, M Fouet, P Hilpert, F Smithies, M Bihari, D Perrotin, D Dequin, PF Tempelhof, G Carton, MJ Payen, D Mateo, J Carlet, J Lescale, O Bleichner, G Sollet, JP Fagon, JY Novara, A Dhainaut, JF Marin, N Galiacy, JL Morteau, B Wolff, M Vachon, F Durocher, A Saulnier, F Herman, B Wysocki, M Duswald, M Radermacher, P Georgieff, M Colardyn, F Robert, D Park, G Mattei, M Charbonneau, P Chopin, C Breulmann, M Holzheimer, M Damas, F Ozier, Y Fraisse, F Gastrinne, H Blanc, PL Domart, Y Aube, H Descamps, JM Nitenberg, G Tempe, JD Bonnet, F Jaeger, A Villers, D Barale, F Falke, K Ulbricht, M Samii, K Pepperman, M Tonnesen, E Gattinoni, L Braschi, A Arich, C Lienhart, A Offenstadt, G Eurin, B Schlemmer, B Goenen, M Bahr, R Brienza, A Antonelli, M Damas, P Edwards, D
Citation: Jfa. Dhainaut et al., Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial, CRIT CARE M, 26(12), 1998, pp. 1963-1971
Risultati: 1-9 |